EFFECT OF HYPERTONIC-HYPERONCOTIC FLUID THERAPY (HHS) ON INTRACRANIAL PRESSURE (ICP) AFTER TRAUMA-TIC BRAIN INJURY (TBI)

P. Fridrich, R. Härtl and W. Mauritz

Dept. of Anesthesia and Critical Care Medicine, Trauma Center „Lorenz Böhler“, Vienna, Austria

Introduction: Small-volume resuscitation with hypertonic saline or HHS has been shown to result in less brain edema and lower ICP values than resuscitation with conventional fluids (1,2,3). The goal of this prospective study was to investigate the effects of HHS on ICP in patients with TBI.
Patients and Methods: 6 patients with TBI (GCS < 8, mean age 32 yrs) were enrolled. Standard treatment included ICP monitoring, mild hyperventilation (pCO2 32-36 mmHg), administration of opioids, sedatives, and mannitol. Patients received the study medication (NaCl 7.5% plus HES 6%, MW 200.000/0.06-0.66; HYPERHESTM; Frese-nius Inc., Austria) if the entry criteria (ICP > 25 mmHg, CPP < 70 mmHg, Na < 150 mmol/l, serum osmolality < 320 mOsm/l) were met. HHS was infused at 20 ml/min until ICP < 25 mmHg and/or CPP > 70 mmHg or a total dose of 250 ml were achieved. HR, ICP, CPP, Na+, K+, Cl-, osmolality, and blood gases were recorded at baseline, 10 and 30 min after HHS. If the entry criteria were met treatment was repeated after a minimum interval of 4 hours.
Results: An average of 171 + 74 ml was infused per treatment. HR, Cl-, and blood gases remained unchanged. Relevant results are given in the table; significant changes (p < 0.05) are indicated by *:
 
MAP  ICP CPP  Na+  K+  Osmo
Baseline 97 45 52 143 4,0 300
SD 19 15 18 5,7 0,5 12
30 min 97 25* 72* 144 4,0 304
SD 21 14 16 5,9 0,5 12

In patient who received repeated doses of HHS ICP reduction varied between 16 and 89% of baseline value. No side effects were observed.
Discussion: Infusion of HHS is now a standard procedure in fluid resuscitation after trauma. The increases in Na+ and osmolality seen immediately after infusion are transient and clinically not relevant. In other studies (4) HHS have been shown to be more effective than mannitol in decreasing ICP. HHS are the drug of choice for fluid resuscitation of trauma patients with severe TBI.
References:
(1) Prough DS, et al. Crit Care Med 1985; 13:407-411
(2) Wisner DH, et al. J Trauma 1990; 30:75-78
(3) Zornow MH, et al. J Trauma 1989; 29:484-488
(4) Schwarz S, et al. Stroke 1998; 29:1550-1555